Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
- 19 December 2005
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 110 (3) , 566-573
- https://doi.org/10.1016/j.jconrel.2005.10.010
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide MicroparticlesJournal of Virology, 2003
- Adjuvants of ImmunityThe Journal of Experimental Medicine, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administrationVaccine, 2000
- Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingScience, 2000
- Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of VaccinesMethods, 1999
- Improving protein therapeutics with sustained-release formulationsNature Biotechnology, 1998
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- Macrophage phagocytosis of biodegradable microspheres composed of L‐lactic acid/glycolic acid homo‐ and copolymersJournal of Biomedical Materials Research, 1988
- Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype ProductionScience, 1987